BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29200852)

  • 1. Natural material-decorated mesoporous silica nanoparticle container for multifunctional membrane-controlled targeted drug delivery.
    Hu Y; Ke L; Chen H; Zhuo M; Yang X; Zhao D; Zeng S; Xiao X
    Int J Nanomedicine; 2017; 12():8411-8426. PubMed ID: 29200852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release.
    Shahein SA; Aboul-Enein AM; Higazy IM; Abou-Elella F; Lojkowski W; Ahmed ER; Mousa SA; AbouAitah K
    Int J Nanomedicine; 2019; 14():5503-5526. PubMed ID: 31410001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactosylated Chitosan-Functionalized Mesoporous Silica Nanoparticle Loading by Calcium Leucovorin for Colon Cancer Cell-Targeted Drug Delivery.
    Liu W; Wang F; Zhu Y; Li X; Liu X; Pang J; Pan W
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30486276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of curcumin loaded multifunctional mesoporous silica nanoparticles to enhance the cytotoxicity for targeted and controlled drug release.
    Chen C; Sun W; Wang X; Wang Y; Wang P
    Mater Sci Eng C Mater Biol Appl; 2018 Apr; 85():88-96. PubMed ID: 29407161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional Mesoporous Silica Nanoparticles Based on Charge-Reversal Plug-Gate Nanovalves and Acid-Decomposable ZnO Quantum Dots for Intracellular Drug Delivery.
    Zhang J; Wu D; Li MF; Feng J
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26666-73. PubMed ID: 26553405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
    Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery.
    Al-Nadaf AH; Dahabiyeh LA; Jawarneh S; Bardaweel S; Mahmoud NN
    Pharm Dev Technol; 2021 Jun; 26(5):582-591. PubMed ID: 33729906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy.
    Lv Y; Cao Y; Li P; Liu J; Chen H; Hu W; Zhang L
    Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28671341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers.
    Yang K; Luo H; Zeng M; Jiang Y; Li J; Fu X
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17399-407. PubMed ID: 26196506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication of Chitosan-coated Mesoporous Silica Nanoparticles Bearing Rosuvastatin as a Drug Delivery System.
    Ghahfarokhi MR; Dini G; Movahedi B
    Curr Drug Deliv; 2022; 19(1):64-73. PubMed ID: 34151762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
    Shen Y; Li M; Liu T; Liu J; Xie Y; Zhang J; Xu S; Liu H
    Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813
    [No Abstract]   [Full Text] [Related]  

  • 13. A self-targeting and controllable drug delivery system constituting mesoporous silica nanoparticles fabricated with a multi-stimuli responsive chitosan-based thin film layer.
    Chen C; Yao W; Sun W; Guo T; Lv H; Wang X; Ying H; Wang Y; Wang P
    Int J Biol Macromol; 2019 Feb; 122():1090-1099. PubMed ID: 30219514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy.
    Narayan R; Gadag S; Cheruku SP; Raichur AM; Day CM; Garg S; Manandhar S; Pai KSR; Suresh A; Mehta CH; Nayak Y; Kumar N; Nayak UY
    Carbohydr Polym; 2021 Jun; 261():117893. PubMed ID: 33766378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
    Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
    Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxylated chitosan-mediated improved efficacy of mesoporous silica nanoparticle-based targeted drug delivery system for breast cancer therapy.
    Lohiya G; Katti DS
    Carbohydr Polym; 2022 Feb; 277():118822. PubMed ID: 34893239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of mesoporous magnetic nanocomposites wrapped with chitosan gatekeepers for pH-sensitive controlled release of doxorubicin.
    Wu J; Jiang W; Shen Y; Jiang W; Tian R
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):132-140. PubMed ID: 27770872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
    Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.